No abstract is available for this article.
Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high-dose therapy / Brioli A;Boyd KD;Kaiser MF;Pawlyn C;Wu P;Gregory WM;Owen R;Ross FM;Jackson GH;Cavo M;Davies FE;Morgan GJ. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - STAMPA. - 161:(2013), pp. 291-294. [10.1111/bjh.12218]
Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high-dose therapy.
BRIOLI, ANNAMARIA;CAVO, MICHELE;
2013
Abstract
No abstract is available for this article.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.